- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis ; volume:9 ; number:1 ; day:19 ; month:12 ; year:2012 ; pages:1-10 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (19.12.2012), 1-10, 12.2012
- Urheber
-
Polak, Paul E.
- Beteiligte Personen und Organisationen
-
Dull, Randall O.
Kalinin, Sergey
Sharp, Anthony J.
Ripper, Richard
Weinberg, Guy
Schwartz, David E.
Rubinstein, Israel
Feinstein, Douglas L.
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-272
- URN
-
urn:nbn:de:1111-2016032332745
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Polak, Paul E.
- Dull, Randall O.
- Kalinin, Sergey
- Sharp, Anthony J.
- Ripper, Richard
- Weinberg, Guy
- Schwartz, David E.
- Rubinstein, Israel
- Feinstein, Douglas L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis
Automated assessment of brain MRIs in multiple sclerosis patients significantly reduces reading time
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis
Automated assessment of brain MRIs in multiple sclerosis patients significantly reduces reading time
Neurodegeneration in multiple sclerosis mouse models
Dorsoventral photobiomodulation therapy safely reduces inflammation and sensorimotor deficits in a mouse model of multiple sclerosis
Cholesterol metabolism in mouse models of Multiple Sclerosis
Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
Dendritic pathology in a mouse model of multiple sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
Multiple sclerosis
Multiple sclerosis